Rotow J, Patel JD, Hanley MP, Yu H, et al. Osimertinib and Selpercatinib Efficacy, Safety, and Resistance in a Multicenter, Prospectively Treated Cohort of EGFR-Mutant and RET Fusion-Positive Lung Cancers. Clin Cancer Res 2023;29:2979-2987.
PMID: 36996322